Rising Drug Patent Portfolio

Rising owns 1 orange book drug protected by 2 US patents Given below is the list of Rising's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7553835 Topical antifungal composition 19 Oct, 2018 Expired
US8026238 Topical antifungal composition 19 Oct, 2018 Expired


Given below is the list of recent legal activities going on the following drug patents of Rising.

Activity Date Patent Number
Patent litigations
Expire Patent 30 Oct, 2023 US8026238
Maintenance Fee Reminder Mailed 15 May, 2023 US8026238
Payment of Maintenance Fee, 8th Year, Large Entity 20 Mar, 2019 US8026238
Change in Power of Attorney (May Include Associate POA) 14 Nov, 2016 US8026238
Email Notification 14 Nov, 2016 US8026238
Correspondence Address Change 10 Nov, 2016 US8026238
Change in Power of Attorney (May Include Associate POA) 01 Oct, 2013 US8026238
Email Notification 01 Oct, 2013 US8026238
Correspondence Address Change 30 Sep, 2013 US8026238
Patent Issue Date Used in PTA Calculation 27 Sep, 2011 US8026238
Recordation of Patent Grant Mailed 27 Sep, 2011 US8026238
Issue Notification Mailed 07 Sep, 2011 US8026238
Dispatch to FDC 26 Aug, 2011 US8026238
Mail Response to 312 Amendment (PTO-271) 25 Aug, 2011 US8026238
Response to Amendment under Rule 312 24 Aug, 2011 US8026238


Rising's Family Patents


Family Patents



Rising Drug List

Given below is the complete list of Rising's drugs and the patents protecting them.


1. Extina

Extina is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7553835 Topical antifungal composition 19 Oct, 2018
(6 years ago)
Expired
US8026238 Topical antifungal composition 19 Oct, 2018
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Extina's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Rising News

Eli Lilly Allocates $1 Billion for Pharmaceutical Production in India - Insights and Data - IndexBox

06 Oct, 2025

Eli Lilly plans to enhance its manufacturing and supply capabilities in India through a $1 billion investment - Irish Examiner

06 Oct, 2025

Costco Pharmacy will provide Ozempic and Wegovy for a monthly fee of $499 - Mass Market Retailers

06 Oct, 2025

For the first time, Colorado is setting its own limits on medication costs - The Washington Post

04 Oct, 2025

See More